CO5590934A2 - Procedimiento de preparacion de derivados de equinocandina - Google Patents

Procedimiento de preparacion de derivados de equinocandina

Info

Publication number
CO5590934A2
CO5590934A2 CO04055277A CO04055277A CO5590934A2 CO 5590934 A2 CO5590934 A2 CO 5590934A2 CO 04055277 A CO04055277 A CO 04055277A CO 04055277 A CO04055277 A CO 04055277A CO 5590934 A2 CO5590934 A2 CO 5590934A2
Authority
CO
Colombia
Prior art keywords
equinocandina
preparation procedure
derivatives preparation
derivatives
dihydrochloride
Prior art date
Application number
CO04055277A
Other languages
English (en)
Spanish (es)
Inventor
Philippe Boffelli
Agnes Brouillard
Colette Colladant
Serge Droux
Michel Elter
Didier Ferroud
Guy Lemaitre
Joseph Paladino
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of CO5590934A2 publication Critical patent/CO5590934A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CO04055277A 2001-12-14 2004-06-11 Procedimiento de preparacion de derivados de equinocandina CO5590934A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0116230A FR2833596B1 (fr) 2001-12-14 2001-12-14 Procede de preparation de derives d'echinocandine

Publications (1)

Publication Number Publication Date
CO5590934A2 true CO5590934A2 (es) 2005-12-30

Family

ID=8870520

Family Applications (1)

Application Number Title Priority Date Filing Date
CO04055277A CO5590934A2 (es) 2001-12-14 2004-06-11 Procedimiento de preparacion de derivados de equinocandina

Country Status (28)

Country Link
US (3) US20070105760A1 (cg-RX-API-DMAC7.html)
EP (1) EP1456229B1 (cg-RX-API-DMAC7.html)
JP (1) JP4510461B2 (cg-RX-API-DMAC7.html)
KR (1) KR20040066167A (cg-RX-API-DMAC7.html)
CN (2) CN100584859C (cg-RX-API-DMAC7.html)
AR (1) AR037827A1 (cg-RX-API-DMAC7.html)
AT (1) ATE441662T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002364991B9 (cg-RX-API-DMAC7.html)
BR (1) BR0214937A (cg-RX-API-DMAC7.html)
CA (1) CA2469918A1 (cg-RX-API-DMAC7.html)
CO (1) CO5590934A2 (cg-RX-API-DMAC7.html)
CY (1) CY1110694T1 (cg-RX-API-DMAC7.html)
DE (1) DE60233589D1 (cg-RX-API-DMAC7.html)
DK (1) DK1456229T3 (cg-RX-API-DMAC7.html)
EA (1) EA007964B1 (cg-RX-API-DMAC7.html)
ES (1) ES2333784T3 (cg-RX-API-DMAC7.html)
FR (1) FR2833596B1 (cg-RX-API-DMAC7.html)
HU (1) HUP0402602A3 (cg-RX-API-DMAC7.html)
IL (1) IL162385A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA04005484A (cg-RX-API-DMAC7.html)
NO (1) NO20042640L (cg-RX-API-DMAC7.html)
NZ (1) NZ533864A (cg-RX-API-DMAC7.html)
PL (1) PL371763A1 (cg-RX-API-DMAC7.html)
PT (1) PT1456229E (cg-RX-API-DMAC7.html)
SI (1) SI1456229T1 (cg-RX-API-DMAC7.html)
TW (1) TWI322820B (cg-RX-API-DMAC7.html)
WO (1) WO2003054001A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200404631B (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2833596B1 (fr) * 2001-12-14 2005-02-18 Aventis Pharma Sa Procede de preparation de derives d'echinocandine
TW200826957A (en) * 2006-10-16 2008-07-01 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Purification processes for echinocandin-type compounds
FR2921060B1 (fr) * 2007-09-14 2012-06-15 Novexel Nouveau procede de preparation d'une piperidine disubsituee et nouveaux intermediaires
FR2936798B1 (fr) * 2008-10-03 2012-09-28 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens.
FR2936951B1 (fr) * 2008-10-10 2010-12-03 Novexel Nouvelles combinaisons de composes heterocycliques azotes antibacteriens avec d'autres composes antibacteriens et leur utilisation comme medicaments
FR2937034B1 (fr) * 2008-10-10 2012-11-23 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens
CN101928670B (zh) * 2009-09-24 2012-02-22 上海天伟生物制药有限公司 一种抗生素的高产菌株及其制备方法和用途
CN102627688B (zh) * 2012-03-30 2014-12-31 上海天伟生物制药有限公司 一种高纯度环肽化合物及其制备方法和用途
CN102627689B (zh) * 2012-03-30 2014-08-06 上海天伟生物制药有限公司 一种环肽类化合物的水合物及其制备方法和用途
CN102659930B (zh) * 2012-03-30 2014-04-23 上海天伟生物制药有限公司 一种高纯度环肽类物质的晶体及其制备方法和用途
WO2016056022A2 (en) * 2014-10-07 2016-04-14 Alaparthi Lakshmi Prasad Intermediates and processes to prepare anidulafungin
CN112646854B (zh) * 2020-12-11 2022-10-11 浙江工业大学 一种棘白菌素b合成培养基及应用
CN115785226B (zh) * 2021-09-09 2026-02-24 上海天伟生物制药有限公司 一种棘白菌素药物杂质及其制备、纯化方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4293484A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912H nucleus
US5207710A (en) * 1988-09-29 1993-05-04 Collagen Corporation Method for improving implant fixation
US5696270A (en) * 1989-05-23 1997-12-09 Abbott Laboratories Intermediate for making retroviral protease inhibiting compounds
US5386009A (en) * 1990-03-19 1995-01-31 Merck & Co. Inc. Lipopeptide derivatives
MY136593A (en) * 1992-03-19 2008-10-31 Lilly Co Eli Cyclic peptide antifungal agents and process for preparation thereof
EP1288224B1 (en) * 1993-08-09 2008-06-25 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Therapeutic peptide derivatives
JP3107691B2 (ja) * 1993-12-03 2000-11-13 株式会社東芝 半導体記憶装置及びその製造方法
ES2181790T3 (es) * 1994-09-16 2003-03-01 Merck & Co Inc Compuestos azaciclohexapeptidicos.
US5646111A (en) * 1995-04-07 1997-07-08 Eli Lilly And Company Cyclic peptide antifungal Agents
US5652213A (en) * 1995-05-26 1997-07-29 Eli Lilly And Company Cyclic peptide antifungal agents
US5852213A (en) * 1996-07-10 1998-12-22 American Cyanamid Company Mercaptoketones and mercaptoalcohols and a process for their preparation
US6207710B1 (en) * 1996-11-22 2001-03-27 Elan Pharmaceuticals, Inc. Compounds for inhibiting β-amyloid peptide release and/or its synthesis
UA72200C2 (uk) * 1997-12-10 2005-02-15 Авентіс Фарма С.А. Похідні ехінокандину, спосіб їх одержання, їх застосування, проміжні сполуки та фармацевтична композиція
FR2794746B1 (fr) * 1999-06-09 2002-12-06 Hoechst Marion Roussel Inc Nouveaux derives de l'echinocandine, leur procede de preparation et leur application comme anti-fongiques
FR2794747B1 (fr) * 1999-06-09 2004-04-16 Hoechst Marion Roussel Inc Nouveaux derives de l'echinocandine, leur procede de preparation et leur application comme anti-fongiques
ATE416189T1 (de) * 1999-07-27 2008-12-15 Aventis Pharma Gmbh Cyclohexapeptide, deren herstellung und verwendung in pharmazeutische zusammensetzungen
FR2833596B1 (fr) * 2001-12-14 2005-02-18 Aventis Pharma Sa Procede de preparation de derives d'echinocandine

Also Published As

Publication number Publication date
CN100584859C (zh) 2010-01-27
SI1456229T1 (sl) 2010-02-26
CN1326872C (zh) 2007-07-18
HK1071900A1 (zh) 2005-08-05
AU2002364991A1 (en) 2003-07-09
FR2833596A1 (fr) 2003-06-20
MXPA04005484A (es) 2004-12-06
JP4510461B2 (ja) 2010-07-21
CY1110694T1 (el) 2015-06-10
CA2469918A1 (fr) 2003-07-03
ES2333784T3 (es) 2010-03-01
BR0214937A (pt) 2004-12-14
JP2005523245A (ja) 2005-08-04
TW200301133A (en) 2003-07-01
HUP0402602A3 (en) 2012-06-28
ATE441662T1 (de) 2009-09-15
NZ533864A (en) 2006-03-31
EP1456229A2 (fr) 2004-09-15
US20070105760A1 (en) 2007-05-10
PT1456229E (pt) 2009-12-10
AU2002364991B2 (en) 2008-05-15
CN1604908A (zh) 2005-04-06
WO2003054001A2 (fr) 2003-07-03
FR2833596B1 (fr) 2005-02-18
DE60233589D1 (de) 2009-10-15
WO2003054001A3 (fr) 2004-01-22
US7148322B2 (en) 2006-12-12
CN1781938A (zh) 2006-06-07
AR037827A1 (es) 2004-12-09
ZA200404631B (en) 2005-01-10
EP1456229B1 (fr) 2009-09-02
KR20040066167A (ko) 2004-07-23
IL162385A0 (en) 2005-11-20
PL371763A1 (en) 2005-06-27
EA200400806A1 (ru) 2004-12-30
US20050032679A1 (en) 2005-02-10
NO20042640L (no) 2004-06-23
EA007964B1 (ru) 2007-02-27
AU2002364991B9 (en) 2008-10-09
US20100273977A1 (en) 2010-10-28
DK1456229T3 (da) 2010-01-04
HUP0402602A2 (hu) 2005-04-28
TWI322820B (en) 2010-04-01
HK1087720A1 (en) 2006-10-20

Similar Documents

Publication Publication Date Title
PA8582801A1 (es) Nuevos derivados espirotricíclicos y su uso como inhibidores de la fosfodiesterasa
ES2190396T3 (es) Nuevos compuestos amino-triazoles, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
BR122019010008B8 (pt) derivados de pirimidina, seu uso, e composição e combinação farmacêuticas
ECSP034460A (es) Nuevos compuestos heterociclicos, su preparacion y su utilizacion como medicamentos, en especial como antibacterianos
UY26872A1 (es) Derivados de la 4- fenil piridina
ES2053508T3 (es) Compuestos de acidos 3-pirrolidinil-tio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilicos.
PY1923494A (es) Derivados de n-(3-(7h-pirrolo[2,3-d]pirimidin-4-il)fenil)benzamida
CR7069A (es) Derivados de pirazol para el tratamiento de vih
UY30498A1 (es) Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones
PE20050012A1 (es) Compuestos de benzopirano como inhibidores de la ciclooxigenasa-2
DK1295890T3 (da) Hidtil ukendte pyrazinderivater eller salte deraf, farmaceutiske præparater, der indeholder derivaterne eller saltene, og mellemprodukter til fremstilling af begge
SE0104140D0 (sv) Novel Compounds
DK0385237T3 (da) 2-(1-Piperazinyl)-4-phenylcycloalkanopyridinderivater, fremgangsmåde til fremstilling deraf og farmaceutisk præparat indeholdende dem
BR0116571A (pt) Compostos heterocìclicos tendo atividade antibacteriana, processo para sua preparação e composições farmacêuticas contendo os mesmos
ECSP045278A (es) Compuestos de oxo-azabicíclicos
AR024390A1 (es) Nuevos compuestos
PA8576101A1 (es) Difenilazetidinonas sustituidas en grupo acido, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso
SV2004001413A (es) Sales de acido succinico de 5,7,14-triazatetraciclo[10.3.1.2,11.04,9]-hexadeca-2(11),3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas ref.pc23247
MXPA03011954A (es) Nuevos derivados de acido sulfonico.
UY29312A1 (es) Piperazin-1-carboxamidas n,4,sustituidas y sus derivados, composiciones que los contienen, procedimientos de preparación y aplicaciones
PA8568101A1 (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso
PY2201650A (es) Nuevos derivados de espirociclohexano, composiciones farmacéuticas que los contienen y sus usos como inhibidores antiapoptóticos
PA8589801A1 (es) Aminoalcoxiindoles
BR0309668A (pt) Imidazolinilmetil aralquilsulfonamidas
EA200400806A1 (ru) Способ получения эхинокандиновых соединений

Legal Events

Date Code Title Description
FG Application granted
FD Application lapsed